12Nov 2021
Prognostic importance of concomitant non‐regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer

Prognostic importance of concomitant non‐regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer

To evaluate the prognostic importance of concomitant non‐regional lymph node (NRLN) and bone metastases in men with synchronous metastatic hormone‐sensitive prostate cancer (mHSPC), determine whether M1b/M1c is the most appropriate M‐stage and evaluate the additional importance to the distinction in low/high volume disease. All men diagnosed with synchronous mHSPC from 2010‐2018 in the Netherlands were identified in the Netherlands Cancer Registry (NCR). Men were categorized as having NRLN (M1a), bone (M1b), NRLN and bone (M1c), or visceral metastases (M1c). For men diagnosed since October 2015, disease volume could be determined. Analyses were performed in this cohort (>5.600 men), and repeated in the 2010‐2018 cohort (>14.000 men). The Primary outcome measure in this observational cohort study was overall survival (OS) and cox regression was used to calculate hazard ratios (HR)...

  • #urology

Like

Save

Share